Saywah Tablet
Marketer
Gonan Pharma
Salt Composition
Flupenthixol (0.5mg) + Melitracen (10mg)
Overview Saywah Tablet
Deprexo Duo tablets combine two active ingredients to alleviate depressive symptoms. This medication works by boosting brain neurotransmitters, promoting relaxation and easing depressive states. Deprexo Duo can be administered with or without food, consistently at the same time daily for optimal therapeutic levels. Always adhere to your physician's prescribed dosage and duration. Abrupt cessation is strongly discouraged; consult your doctor before discontinuing treatment to avoid symptom exacerbation. Potential side effects include xerostomia, constipation, urinary retention, blurred vision, tachycardia, muscle stiffness, akathisia, and tremor. Postural hypotension may occur initially; rise slowly from sitting or lying positions. Dizziness and somnolence are also possible; refrain from driving or activities demanding concentration until the medication's effects are understood. Prior to commencing treatment, disclose any pre-existing conditions such as thyroid or kidney disease, epilepsy, Parkinson's disease, glaucoma, or cardiovascular disease. Weight gain is a potential consequence; maintain a healthy diet, limit high-calorie snacks, and engage in regular exercise.
Primary Ingredients of Saywah Tablet
There is no text provided to rephrase.
Uses of Saywah Tablet
Managing Depressive Disorders
Major Benefits of Saywah Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Saywah Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Saywah Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Saywah Tablet:
- Constipation
- Urinary retention
- Weight gain
- Sleepiness
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Increased heart rate
- Increased prolactin level in blood
- Blurred vision
- Dryness in mouth
- Muscle stiffness
- Tremors
- Restlessness
How to use Saywah Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Saywah Tablets. Ingest the tablets whole; avoid crushing, chewing, or breaking them. While Saywah Tablets can be taken with or without food, consistent timing is recommended for optimal results.
How Saywah Tablet works:
Saywah Tablet combines flupenthixol, a conventional antipsychotic, with melitracen, a tricyclic antidepressant. Flupenthixol's mechanism involves dopamine receptor antagonism, modulating neurotransmission implicated in mood and cognition. Melitracen elevates levels of key neurotransmitters, counteracting mood imbalances characteristic of depressive disorders.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Saywah Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Saywah Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Saywah Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving should be avoided if you experience drowsiness, blurred vision, dizziness, or reduced attentiveness after taking Saywah Tablet.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Saywah Tablet's efficacy and safety in individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Saywah Tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Saywah Tablet :
Should you forget a Saywah Tablet dose, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Saywah Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Neuroscience Central Nervous System |



